These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 574057)

  • 41. Genitourinary malignancy.
    Leighton J; Clark J; Giantonio B; Ozols R; Hudes G
    Cancer Chemother Biol Response Modif; 1996; 16():524-63. PubMed ID: 8639400
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intra-arterial infusion of antineoplastic agents in the treatment of urogenital cancer].
    Uyam T; Moriwaki S
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):415-20. PubMed ID: 7184407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer chemotherapy in urology.
    Furnari S; Pavone-Macaluso M; Veroux G; Mattea E
    Urol Int; 1971; 26(4):315-20. PubMed ID: 4331514
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chemotherapy and radiotherapy for urological cancer].
    Miyanaga N; Tsukamoto S; Hattori K; Kawai K; Shimazui T; Uchida K; Akaza H
    Gan To Kagaku Ryoho; 2002 May; 29(5):709-16. PubMed ID: 12040674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.
    Bosl GJ; Kwong R; Lange PH; Fraley EE; Kennedy BJ
    Cancer Treat Rep; 1980; 64(2-3):331-4. PubMed ID: 6157467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy of urologic malignancies.
    Scher HI; Sternberg CN
    Semin Urol; 1985 Nov; 3(4):239-80. PubMed ID: 3916569
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pretherapeutic testing of sensitivity to cytostatic drugs in primary cultures of selected urologic tumors].
    Klatte D; Redmann K; Müller GW; Richter A; Gabriel D
    Z Urol Nephrol; 1986 Aug; 79(8):441-7. PubMed ID: 2430377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. cis-Dichlorodiamminepltinum(II) in adult patients: Southwest Oncology Group Studies.
    Stephens R; Coltman C; Rossof A; Samson M; Panettiere F; Al-Sarraf M; Alberts D; Bonnet J
    Cancer Treat Rep; 1979; 63(9-10):1609-10. PubMed ID: 498160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of non-seminomatous testicular tumors in combination with vinblastine/bleomycin and adriamycin/cisplatin].
    Boewer C; Fleck H; Uibel M; Nawka S
    Z Urol Nephrol; 1982 May; 75(5):315-23. PubMed ID: 6180571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
    Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of early urogenital cancer].
    Rinsho K; Koiso K
    Gan No Rinsho; 1984 May; 30(6 Suppl):653-8. PubMed ID: 6748240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequential combination chemotherapy with vinblastine-bleomycin and doxorubicin-cis-dichlorodiammineplatinum(II) in disseminated nonseminomatous testicular cancer.
    Scheulen ME; Seeber S; Schilcher RB; Meier CR; Schmidt CG
    Cancer Treat Rep; 1980; 64(4-5):599-609. PubMed ID: 6159077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemotherapy of urologic neoplasms.
    Koven BJ
    J Med Soc N J; 1970 Oct; 67(10):617-20. PubMed ID: 5273709
    [No Abstract]   [Full Text] [Related]  

  • 54. Biennial report on genitourinary cancers.
    Fizazi K
    Eur J Cancer; 2016 Oct; 66():125-30. PubMed ID: 27569040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cisplatin].
    Millá A; Grau JJ; Estapé J
    Med Clin (Barc); 1983 Feb; 80(6):283-8. PubMed ID: 6345956
    [No Abstract]   [Full Text] [Related]  

  • 56. Circadian chemotherapy for gynecological and genitourinary cancers.
    Kobayashi M; Wood PA; Hrushesky WJ
    Chronobiol Int; 2002 Jan; 19(1):237-51. PubMed ID: 11962679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ototoxicity of cis-diammine glycolato platinum, 254-S].
    Horiuchi M; Miyake H; Ota K
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1327-32. PubMed ID: 1503488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genitourinary malignancy.
    Giantonio B; Ozols RF; Hudes GR
    Cancer Chemother Biol Response Modif; 1993; 14():498-529. PubMed ID: 8312117
    [No Abstract]   [Full Text] [Related]  

  • 59. Future directions for gemcitabine in the treatment of genitourinary cancer.
    Vogelzang NJ
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):40-5. PubMed ID: 11894007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical studies of bestatin on genitourinary cancer].
    Ichikawa T; Hirokawa I; Ishihara Y
    Jpn J Antibiot; 1985 Jan; 38(1):166-78. PubMed ID: 3989976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.